Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage
- PMID: 28265237
- PMCID: PMC5330164
- DOI: 10.1515/raon-2016-0035
Incidence of positive peritoneal cytology in patients with endometrial carcinoma after hysteroscopy vs. dilatation and curettage
Abstract
Background: The aim of the study was to compare the frequency of positive peritoneal washings in endometrial cancer patients after either hysteroscopy (HSC) or dilatation and curettage (D&C).
Patients and methods: We performed a retrospective analysis of 227 patients who underwent either HSC (N = 144) or D&C (N = 83) and were diagnosed with endometrial carcinoma at the University Medical Centre Maribor between January 2008 and December 2014. The incidence of positive peritoneal cytology was evaluated in each group.
Results: There was no overall difference in the incidence of positive peritoneal washings after HSC or D&C (HSC = 13.2%; D&C = 12.0%; p = 0.803). However, a detailed analysis of stage I disease revealed significantly higher rates of positive peritoneal washings in the HSC group (HSC = 12.8%; D&C = 3.4%; p = 0.046). Among these patients, there was no difference between both groups considering histologic type (chi-square = 0.059; p = 0.807), tumour differentiation (chi-square = 3.709; p = 0.156), the time between diagnosis and operation (t = 0.930; p = 0.357), and myometrial invasion (chi-square = 5.073; p = 0.079).
Conclusions: Although the diagnostic procedure did not influence the overall incidence of positive peritoneal washings, HSC was associated with a significantly higher rate of positive peritoneal cytology in stage I endometrial carcinoma compared to D&C.
Keywords: FIGO staging; dilatation and curettage; endometrial carcinoma; hysteroscopy; peritoneal cytology.
Similar articles
-
Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D & C) versus hysteroscopy and D & C.Cancer. 2000 Jan 1;88(1):139-43. Cancer. 2000. PMID: 10618616
-
Does hysteroscopy worsen prognosis in women with type II endometrial carcinoma?PLoS One. 2017 Mar 23;12(3):e0174226. doi: 10.1371/journal.pone.0174226. eCollection 2017. PLoS One. 2017. PMID: 28334032 Free PMC article.
-
Office hysteroscopy and the risk of microscopic extrauterine spread in endometrial cancer.Gynecol Oncol. 2007 Oct;107(1):94-8. doi: 10.1016/j.ygyno.2007.05.031. Epub 2007 Jul 3. Gynecol Oncol. 2007. PMID: 17610939
-
Safety of diagnostic hysteroscopy for the investigation of type II endometrial cancer: systematic review with meta-analysis.BMJ Open. 2024 Nov 1;14(10):e087582. doi: 10.1136/bmjopen-2024-087582. BMJ Open. 2024. PMID: 39486826 Free PMC article.
-
Controversy on Positive Peritoneal Cytology of Endometrial Carcinoma.Comput Math Methods Med. 2022 Apr 1;2022:1906769. doi: 10.1155/2022/1906769. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Jun 28;2023:9814020. doi: 10.1155/2023/9814020. PMID: 35401781 Free PMC article. Retracted. Review.
Cited by
-
The Impact of Positive Peritoneal Cytology on the Survival Rates of Early-Stage-Disease Endometrial Cancer Patients: Systematic Review and Meta-Analysis.Medicina (Kaunas). 2024 Apr 28;60(5):733. doi: 10.3390/medicina60050733. Medicina (Kaunas). 2024. PMID: 38792916 Free PMC article.
-
Comparison of prognosis of patients with endometrial cancer after hysteroscopy versus dilatation and curettage: A multicenter retrospective study.Front Med (Lausanne). 2023 Jan 9;9:1097133. doi: 10.3389/fmed.2022.1097133. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36698830 Free PMC article.
-
Metastases and Recurrence Risk Factors in Endometrial Cancer-The Role of Selected Molecular Changes, Hormonal Factors, Diagnostic Methods and Surgery Procedures.Cancers (Basel). 2023 Dec 29;16(1):179. doi: 10.3390/cancers16010179. Cancers (Basel). 2023. PMID: 38201606 Free PMC article. Review.
-
Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report.Mol Clin Oncol. 2020 Aug;13(2):141-145. doi: 10.3892/mco.2020.2053. Epub 2020 May 27. Mol Clin Oncol. 2020. PMID: 32714537 Free PMC article.
-
Surgical treatment and fertility perservation in endometrial cancer.Radiol Oncol. 2021 Feb 11;55(2):144-149. doi: 10.2478/raon-2021-0009. Radiol Oncol. 2021. PMID: 33583160 Free PMC article.
References
-
- Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye AB. et al. Society of Gynecologic Oncology Clinical Practice Committee. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol. 2014;134:385–92. - PubMed
-
- Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002;288:1610–21. - PubMed
-
- Gkrozou F, Dimakopoulos G, Vrekoussis T, Lavasidis L, Koutlas A, Navrazoglou I. et al. Hysteroscopy in women with abnormal uterine bleeding: a metaanalysis on four major endometrial pathologies. Arch Gynecol Obstet. 2015;291:1347–54. - PubMed
-
- Gu M, Shi W, Huang J, Barakat RR, Thaler HT, Saigo PE. Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer. 2000;90:143–7. - PubMed
-
- Selvaggi L, Cormio G, Ceci O, Loverro G, Cazzolla A, Bettocchi S. Hysteroscopy does not increase the risk of microscopic extrauterine spread in endometrial carcinoma. Int J Gynecol Cancer. 2003;13:223–7. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources